ClinVar Miner

Submissions for variant NM_025193.4(HSD3B7):c.205C>T (p.Gln69Ter)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Neuberg Centre For Genomic Medicine, NCGM RCV003338018 SCV004048555 likely pathogenic Congenital bile acid synthesis defect 1 criteria provided, single submitter clinical testing The stop gained p.Q69* in HSD3B7 (NM_025193.4) has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Q69* variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. This variant is predicted to cause loss of normal protein function through protein truncation. The p.Q69* variant is a loss of function variant in the gene HSD3B7, which is intolerant of Loss of Function variants. The nucleotide change in HSD3B7 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Likely Pathogenic. The observed variant is also detected in the spouse.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.